




版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
Thyroiddisease
LiboLiMD
DepartmentofGeneralSurgery
SirRunRunShawHospital
Schoolofmedicine,ZhejiangUniversity
Thyroiddisease
LiboLiMD
AnatomyofThyroidAnatomyofThyroidAnatomyofThyroidAnatomyofThyroidThyroiddiseaseNontoxicgoiterHyperthyroidismThyroidCancerThyroiditisThyroiddiseaseNontoxicgoiterNontoxicGoiterGoiterfromtheFrench(goitre)andLatin(guttur),bothmeaningthroatDefinedasanenlargementofthethyroidglandEndemicwhenitinvolvesmorethan10%ofthepopulationThemajority,secondarytoiodinedeficiencyEspeciallyfoundinhighmountainregionsNontoxicGoiterGoiterfromtheNontoxicGoiter
ClinicalthinkingWhetherthepatienthaslocalsymptomsWhetherthegoiteristoxicornontoxicWhetheranyofthenodulesharboracancerThenumberandbilateralityofthenodulesTSHlevel,differentialdiagnosisofhypothyroidismorhyperthyroidismAppropriatetreatmentoptionsforeachparticularpatient
NontoxicGoiter
TakinghistoryAsymptomaticneckmassAcough,shortnessofbreath,stridor,orhoarsenessChokingoraspiration,dysphagia,orpainSymptomsofhyperthyroidismWhetherthepatienthascosmeticconcernsFromiodinedeficiencyregion
NontoxicGoiter
PhysicalexaminationWhetherthegoiterisconfinedtotheneckWhetherithasasubsternalcomponentWhethertrachealdeviationispresentThesizeandconsistencyofthegoiterThemobilityofthevocalcordsbyeitherindirectordirectlaryngoscopy
NontoxicGoiter
UltrasoundHowmanynodules?Bilateral?Ultrasoundcharacteristics
NontoxicGoiterCTscanNeckandchest,especiallysubsternalthyroidRareintrathoracicoraberrantthyroidNontoxicGoiterCTscanNontoxicGoiterFineneedleaspiration(FNA)SuspiciousmalignentgoiterNontoxicGoiterFineneedleaspNontoxicGoiter
TreatmentIodinedietreplacement(endemicgoitor)SurgicalresectionSymptomsLocalcompressionSecondaryhyperthyroidisimAnysuspiciousormalignantlesionCosmeticreasonsRadioiodinetherapy,highriskofptsThyroidhormonesuppression(notforsporadicgoiter)
SporadicNontoxicGoiterAsymptomaticEuthyroidMostbilaterallyNoefficiencyofthyroidhormonereplacementHighrecurrencepostoperatively30%~40%SporadicNontoxicGoiterAsymptNontoxicGoiter
HistoryofThyroidSurgeryFirstthyroidectomy,inParisin1791byPierre-JosephDesaultAntisepsis,hemostasis,andgeneralanesthesiainthe1840sthyroidsurgerybecamesafeTheodoreKocher,aNobelPrizein1909FromBern,SwitzerlandHispioneeringeffortsinthyroidsurgery
PrimaryHyperthyroidsim
Grave’sDiseasePrimaryHyperthyroidsim
GraveClinicalStatisticsGravesDiseaseisthemostcommoncauseofhyperthyroidism(60-80%)ofallcasesFemalesareaffectedmorefrequentlythanmen10:1.5Monozygotictwinsshow50%concordanceratesIncidencepeaksfromages20-40IncidenceissimilarinwhitesandAsians,butissomewhatdecreasedforAfricanAmericansClinicalStatisticsGravesDiseGraves'DiseaseAutoimmunesystemicdisorderThyroidreceptorantibodybindingtoandstimulatingtheTSHreceptorExcessivesynthesisandsecretionofthyroidhormoneUsuallydiffuselyandsymmetricallyenlargedandfirmGraves'DiseaseAutoimmunesystHyperthyroidism—uptakeA.NormalB.Graves’DzC.ToxicMultinodularGoiterD.ToxicAdenomaE.ThyroiditisHyperthyroidism—uptakeA.NormaHyperthyroidism
SymptomsHeatintolerance,sweating,palpitations,fatigueWeightloss,diaphoresis,increasedstoolfrequencyMuscleweakness,anxiety,insomniaNervousnessorrestlessness;irritability,emotionallabilityInwomen,irregularmenses
Hyperthyroidism
ClinicalfindingsTremor,tachycardia(A.fib),Goiter,lidlag,proptosis,periorbitaledema,exophthalmos;chemosis;hyperreflexiaWarm,moistskin;dermopathy;andpretibialedema,
osteoporosis
ExopthalamosinGravesDiseaseLidLaginGravesDiseaseExopthalamosinGravesDiseaseHyperthyroidism—treatmentBeta-blockers:controlsxsPropranololdecrperipheralT4->T3conversionGraves’DzPTU(safeinpregnancy)ormethimazoleRaresideeffect:agranulocytosisRadioactiveiodine75%oftreatedptsbecomehypothyroidSurgeryToxicAdenomaorTMNGRAIorsurgeryHyperthyroidism—treatmentBeta-Hyperthroidism
SurgerySurgicalapproachBilateralnear-totalortotalthyroidectomyIndicationofsurgery(InChina)CompressivesymptomsSecondaryoradenomaRecurrenceofmedicineoriodine-131NoefficiencyofmedicineSecondtrimesterofpregnancy
Surgeryforhyperthyroidism
PreoperativepreparationAbsolutelyrequiredantithyroiddrugs,for3to6weekswithagoalofnearlynormalizingtheT3andT4PropranololoratenololrapidlycontrolstheadrenergicsideeffectsofexcessT4andT3tachycardia,tremor,anddiaphoresisLugol'ssolutionrapidlybuttemporarilyrestoresnormalthyroidfunctionandreducesthyroidglandvascularity
SurgicalcomplicationsBleedingRecurrentLaryngealNerveDamageHypoparathyroidismandHypocalcemiaSuperiorlaryngealnervedamageThyroidstormSurgicalcomplicationsBleedinThyroidcancerThyroidcancerThyroidcancer
IntroductionThemostcommon,95%ofallendocrinecancersIncreasingfasterthananyothercancerMorethan90%,welldifferentiatedGoodlong-termprognosis
Thyroidcancer
ClinicalPresentationMost,clinicallywithapalpablenoduleUsuallyasymptomaticRarecases,withhoarseness,pain,dysphagia,dyspnea,coughing,orchokingspellsPain,withthesuspicionforMedullarythyroidcarcinomaAnaplasticcarcinomaLymphoma
PertinenthistoricalfactorspredictingmalignancyAhistoryofheadandneckirradiationTotalbodyirradiationforbonemarrowtransplantationExposuretofalloutfromtheexplosionoftheChernobylnuclearpowerplantin1986,especiallyinchildren;Afamilyhistoryofthyroidcancer;andrapidgrowthorhoarseness.Children,men,andadultsolderthan60yearshaveanincreasedriskofmalignancyPertinenthistoricalfactorspIncreasetheriskofthyroidcancerPersonalandfamilyhistoryofotherendocrinedisorders,specificallyhyperparathyroidism,pituitaryadenomas,pancreaticisletcelltumors,adrenaltumors,andbreastcancer.Afamilyhistoryofpapillaryormedullarycarcinoma(MENsyndromes),familialpolyposis,Gardner'ssyndrome,andCowden'ssyndromeIncreasetheriskofthyroidcPertinentphysicalfindingsSuggestingpossiblemalignancyGrittytexture”(顆粒樣)ofthethyroidnoduleCervicallymphadenopathyVocalcordparalysisFixationofthenoduletosurroundingtissuePertinentphysicalfindingsSuThyroidcancer
DiagnosisUltrasoundFeatureofmalignancyIrregularmarginsIntranodularvascularpatternMicrocalcificationsFineneedleaspiration(FNA)Themostreliableandcost-efficientmethod
Thyroidcancer
DiagnosisThyroidfunctiontestsSerummarkersThyroglobulin(TG)forwell-differentiatedthyroidcancerCalcitoninandCEAformedullarythyroidcancerAllptswithmedullarythyroidcancerRETproto-oncogenepheochromocytomaandhyperparathyroidism
Managementofthyroidcancer
ThegoalsoftherapyRemovalofprimarytumor,diseasethatextendsbeyondthethyroidcapsule,andinvolvedcervicallymphnodesMinimizationoftreatment-anddisease-relatedmorbidityAccuratediseasestagingFacilitationofpostoperativetreatmentwithradioiodinewhenappropriateAccuratelong-termsurveillanceMinimizationoftheriskofrecurrentlocalandmetastatictumor
Well-DifferentiatedThyroidCarcinoma
PapillaryThyroidCarcinoma
Themostcommonendocrinemalignancy,approximately80%ofnewcasesAssociatedwiththebestprognosisAtleasttwiceascommoninwomenasmenApeakageofpresentationof38to45years90%ofradiation-induced,familialin5%
PapillaryThyroidCarcinomaPapillaryThyroidCarcinomaWell-DifferentiatedThyroidCarcinoma
PrognosesTheriskofdeathapproximately5%inthelow-riskgroup40%inthehigh-riskgroupFortunately,mostpts(70%)inthelow-riskgroup
OtherhistologicalfactorsTopredictthebehaviorofthyroidcancerPloidyofthetumorAdenylatecyclaseresponsetothyroidstimulatinghormone(TSH)RadioiodineuptakeApositivepositronemissiontomographyscanEpidermalgrowthfactor(EGF)receptorlevelandvariousgeneprofilesOtherhistologicalfactorsToPapillaryThyroidCarcinoma
Theextentofsurgicalresection
ControversialAmericanrecommondationTotalorneartotalthyroidectomy
complicationrateoflessthan2%SelectivenodalresectionPostoperativetreatmentwithiodine-131Low-riskptslessthan1cmthyroidlobectomyandisthmectomyOKReoperationmultifocal,withnodalmetastases,orwithlocalinvasion
BenefitsoftotalthyroidectomyPostoperativeradioiodinescanningandablativetherapycanbeeffectiveSerumthyroglobulinlevelsarerenderedmoresensitivefordetectingrecurrentorpersistentdiseaseIntrathyroidalcancerthatispresentinmorethan50%ofpatientsisremovedThesmallriskofadifferentiatedthyroidcancerbecominganundifferentiatedcancerisdecreased.BenefitsoftotalthyroidectomPapillaryThyroidCarcinoma
Theroleoflymphnodedissection
AlsocontroversialMicrometastasistocervicallymphnodesiscommon(80%)ProphylacticcervicallymphnodedissectionisnotwarrantedFunctionalneckdissectionandcentralneckdissectionshouldgenerallybeperformedonlyinptswithclinicalorsonographicevidenceoflymphnodeinvolvement
FollicularThyroidCarcinomaApproximately10%ofallthyroidmalignanciesTypicallyolderthanPTCUsuallyinthesixthdecadeoflifeThefemale-to-maleratioisbetween2:1and5:1AslowlygrowingsolitarythyroidnoduleAtendencytospreadhematogenouslyRarelywithsymptomsofdistantmetastasistothebone,lung,brain,andliverFollicularThyroidCarcinomaApFollicularThyroidCarcinomaLessthan6%metastasizetothecervicallymphnodesApproximately25%ofptshaveextrathyroidalinvasion10%to33%havedistantmetastasisatthetimeofinitialdiagnosisFollicularThyroidCarcinomaLeTheprognosisoffollicularcancerSlightlyworsethanthatforpapillarycancerOverallsurvivalrangesfrom43%to95%at10yearsLifelongsurveillanceisnotnecessaryTheprognosisoffollicularcaTheprognosisoffollicularcancerTheimportantprognosticfactorsPresenceofmetastaticdiseaseOlderage(usually>40years)Degreeofinvasion(microcapsularvs.angioinvasionwithorwithoutcapsularandwidelyinvasive)DegreeoftumordifferentiationTheprognosisoffollicularcaFollicularThyroidCarcinomaDiagnosisThewholespecimenmustbeevaluatedforvascularandcapsularinvasion.DiagnosisoffollicularcancercannotbemadeonFNABFollicularThyroidCarcinomaDiFollicularThyroidCarcinomaTreatmentTherecommendedinitialoperationislobectomyandisthmectomyLymphnodedissectionisrarelywarrantedbecausenodalmetastasesareuncommonFollicularThyroidCarcinomaTrMedullaryThyroidCarcinoma7%ofthyroidcancers15%ofallthyroidcancer–relateddeathsApprox75%sporadic零星的,25%hereditaryFromccellsorparafollicularcellsLocatedlaterallyatthejunctionoftheuppertwothirdsofthethyroidglandatapproximatelythelevelofthecricoidcartilageMedullaryThyroidCarcinoma7%MedullaryThyroidCarcinomaInthesporadicformUsuallyasinglefocusofmalignancyUnilateraldiseasein85%ofcasesInthehereditaryformMultifocalandbilateralin90%ofcasesC-cellhyperplasiaMedullaryThyroidCarcinomaInThehereditaryformsofMTCThehereditaryformsofMTCMedullaryThyroidCarcinoma
TumormarkerSerummarkersforcalcitoninsupportthediagnosiscorrelatewithtumorbulk,nodal,anddistantmetastasisHighCEAlevelscorrelatewithapoorerprognosisFlushinganddiarrheaalsohaveaworseprognosis
MedullaryThyroidCarcinoma
LymphnodemetastasesPositivein70%ofpatients81%ofpatientshadcentralnodedisease81%hadipsilateralcervicalnodedisease44%hadcontralateralcervicalnodaldisease
PreventionorcureofMTCBysurgerymainlydependentontheinitialstageandtheadequacyoftheinitialoperationIndicationRET-positivepatientswithfamilialdiseasebeforetheageofpossiblemalignantprogressiontotalthyroidectomybeforeage6PreventionorcureofMTCBysuSurgicalmanagementforMTCDependsonthepresentationofthediseaseThyroidectomyandcentralnodedissectionCentrallymphnodedissectionsincreasetheriskofrecurrentlaryngealnerveinjuryandhypoparathyroidismSurgicalmanagementforMTCDeAnaplasticThyroidCarcinomaRare,1%to2%ofthyroidmalignanciesMorethanhalfofthedeathsfromthyroidcancerSurvivalismeasuredinmonthsCommonlyinpatientsolderthan60yearsUsuallypresentsasarapidlyexpandingthyroidmassAnaplasticThyroidCarcinomaRaAnaplasticThyroidCarcinomaLymphnodeenlargementFrequent(84%)andearlyLocaltumorextensioncauseFixationofthelarynx,esophagus,andcarotidvesselsDysphagia,dysphonia,anddyspneaarecommonSystemicmetastasesoccurin75%ofpts,Usuallyinvolvingthelungs,bone,brain,andadrenalglandsAnaplasticThyroidCarcinomaLyAnaplasticThyroidCarcinomaThediagnosisBeestablishedbyFNABDifferentiatedfromthatoflymphomaandpoorlydifferentiatedmedullarycarcinomaAnaplasticThyroidCarcinomaThAnaplasticThyroidCarcinoma
SurgeyUsuallynotcurative,withdistantmetastasesMultimodalitytreatment,slightlyimprovedoutcomesIndicatelocalcontrolin22%to76%ofptsMediansurvivalrangesfrom2.5to9months,with2-yearsurvivaloflessthan20%
SubacuteThyroiditisPainlessThyroiditisPainfulThyroiditisRareSubacuteThyroiditisPainlessTPainlessThyroiditisAlsocalledlymphocyticthyroiditisSpontaneouslyresolvinghyperthyroidismAnautoimmunedisorderTypicallyelevatedthyroidperoxidaseantibodylevelsLymphocyticinfiltrationofthethyroidPainlessThyroiditisAlsocallePainlessThyroiditis
ClinicalPresentationAgesof30and60years40%ptswiththeclassicalafour-stageclinicalcourse(1)Destruction-inducedthyrotoxicosis,(2)euthryoidism,(3)hypothyroidism,and(4)returntoeuthyroidismUsually,firmglandandnon-tenderwithsymmetrical,modestenlargementNearlyonethirdofpts,permanentlyhypothyroid
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 生活污水運(yùn)輸合同協(xié)議
- 用合伙協(xié)議代替勞動(dòng)合同
- 玩具代加工合作合同協(xié)議
- 2025至2030年中國(guó)移動(dòng)式穩(wěn)定土廠拌設(shè)備數(shù)據(jù)監(jiān)測(cè)研究報(bào)告
- 2025至2030年中國(guó)電瓶車電鍍小鏡數(shù)據(jù)監(jiān)測(cè)研究報(bào)告
- 2025至2030年中國(guó)豬苓多糖注射液數(shù)據(jù)監(jiān)測(cè)研究報(bào)告
- 2025至2030年中國(guó)液壓角鋼切斷機(jī)數(shù)據(jù)監(jiān)測(cè)研究報(bào)告
- 2025至2030年中國(guó)正聯(lián)鎖閥數(shù)據(jù)監(jiān)測(cè)研究報(bào)告
- 2025至2030年中國(guó)智能明渠流量計(jì)數(shù)據(jù)監(jiān)測(cè)研究報(bào)告
- 2025至2030年中國(guó)時(shí)裝帽數(shù)據(jù)監(jiān)測(cè)研究報(bào)告
- 《職業(yè)衛(wèi)生》專題培訓(xùn)
- 上海虹口區(qū)江灣鎮(zhèn)街道社區(qū)工作者招聘筆試真題2023
- 銀行辦公大樓物業(yè)服務(wù)投標(biāo)方案投標(biāo)文件(技術(shù)方案)
- 寵物醫(yī)院安樂(lè)協(xié)議書范文模板
- 鄉(xiāng)村振興大數(shù)據(jù)基礎(chǔ)數(shù)據(jù)元與代碼集
- 下水疏通施工合同模板
- 酒店消防疏散應(yīng)急預(yù)案
- 護(hù)理中醫(yī)院感染問(wèn)題課件
- 五年級(jí)語(yǔ)文下冊(cè)期中復(fù)習(xí)課件
- 布置我們的家(課件)三年級(jí)下冊(cè)綜合實(shí)踐活動(dòng)滬科黔科版
- 畢業(yè)論文(設(shè)計(jì))多功能臺(tái)燈設(shè)計(jì)
評(píng)論
0/150
提交評(píng)論